GC Biopharma
Yongin, South Korea
GC Biopharma (formerly Green Cross) is a South Korean biopharmaceutical company specializing in plasma-derived therapies. Their IVIG product, Alyglo, is indicated for PIDD. GC Biopharma has been expanding its presence in the U.S. market for immunoglobulin products.
Drugs
Hub Program — GC Biopharma Patient Support
- ✓Insurance verification
- ✓Prior authorization support
- ✓Patient assistance for eligible patients
- ✓Infusion coordination support
Patient Assistance
Copay Assistance
Contact GC Biopharma directly for information about copay assistance programs.
Patient Assistance Program (PAP)
GC Biopharma offers patient assistance for eligible uninsured patients. Contact their patient support line for details.
Denied a GC Biopharma Drug?
Ellen can decode your denial, identify the specific reason, and generate a personalized appeal letter — free.